Substance P and Thiorphan Synergically Enhance Angiogenesis in Wound Healing

다국어 초록 (Multilingual Abstract)

Impaired angiogenesis is a common pathological characteristic of chronic wounds. Therefore, the regulation of angiogenesis is important for proper tissue repair. It was reported that substance P (SP) accelerates wound healing in a skin injury model. SP is degraded by neutral endopeptidase (NEP). Our study shows that systemic co-treatment of SP and thiorphan, an inhibitor of NEP synergically increased the number of α-smooth muscle actin positive-blood vessels in skin wounds. However, there was no synergic improvement in wound contraction and extracellular matrix deposition. Therefore, inhibition of endogenous NEP activity by thiorphan treatment might modulate the effects of SP treatment specifically on accelerating angiogenesis during wound healing. However, the molecular mechanism(s) of the synergic increase in angiogenesis by SP and thiorphan treatment is still unknown.

참고문헌 (Reference)

1 Kant V, "Topically applied substance P enhanced healing of open excision wound in rats" 715 : 345-353, 2013

2 Medja F, "Thiorphan, a neutral endopeptidase inhibitor used for diarrhoea, is neuroprotective in newborn mice" 129 (129): 3209-3223, 2006

3 Koh YH, "The role of neutral endopeptidase in caerulein-induced acute pancreatitis" 187 : 5429-5439, 2011

4 Matsas R, "The metabolism of neuropeptides. The hydrolysis of peptides, including enkephalins, tachykinins and their analogues, by endopeptidase-24.11" 223 : 433-440, 1984

5 장태정, "The Expression of CD10 and CD15 Is Progressively Increased during Colorectal Cancer Development" 대한병리학회 47 (47): 340-347, 2013

6 Park PJ, "Substance P stimulates endothelin 1 secretion via endothelin-converting enzyme 1 and promotes melanogenesis in human melanocytes" 135 : 551-559, 2015

7 Yang L, "Substance P promotes diabetic corneal epithelial wound healing through molecular mechanisms mediated via the neurokinin-1 receptor" 63 : 4262-4274, 2014

8 Dubon MJ, "Substance P enhances the proliferation and migration potential of murine bone marrow-derived mesenchymal stem cell-like cell lines" 9 : 1185-1191, 2015

9 Davies KP, "Sialorphin(the mature peptide product of Vcsa1)relaxes corporal smooth muscle tissue and increases erectile function in the ageing rat" 99 : 431-435, 2007

10 Werner S, "Regulation of wound healing by growth factors and cytokines" 83 : 835-870, 2003

11 Horiguchi A, "Neutral endopeptidase inhibits prostate cancer tumorigenesis by reducing FGF-2-mediated angiogenesis" 11 : 79-87, 2008

12 Olerud JE, "Neutral endopeptidase expression and distribution in human skin and wounds" 112 : 873-881, 1999

13 Antezana M, "Neutral endopeptidase activity is increased in the skin of subjects with diabetic ulcers" 119 : 1400-1404, 2002

14 Roques BP, "Neutral endopeptidase 24.11: structure, inhibition, and experimental and clinical pharmacology" 45 : 87-146, 1993

15 Indig FE, "Neutral endopeptidase (EC 3.4.24.11) is highly expressed on osteoblastic cells and other marrow stromal cell types" 172 : 620-626, 1990

16 Goodman OB Jr, "Neprilysin inhibits angiogenesis via proteolysis of fibroblast growth factor-2" 281 : 33597-33605, 2006

17 Mitra R, "Negative regulation of NEP expression by hypoxia" 73 : 706-714, 2013

18 Rasini V, "Mesenchymal stromal/stem cells markers in the human bone marrow" 15 : 292-306, 2013

19 Kohn LA, "Lymphoid priming in human bone marrow begins before expression of CD10 with upregulation of L-selectin" 13 : 963-971, 2012

20 Robins SP, "Increased skin collagen extractability and proportions of collagen type III are not normalized after 6 months healing of human excisional wounds" 121 : 267-272, 2003

21 Tonnesen MG, "Angiogenesis in wound healing" 5 : 40-46, 2000

22 Hong HS, "A new role of substance P as an injury-inducible messenger for mobilization of CD29(+)stromal-like cells" 15 : 425-435, 2009

23 Kletsas D, "11(NEP)activity in human fibroblasts during development and ageing" 102 : 15-23, 1998